These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6752282)

  • 21. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber.
    Håkansson L; Venge P
    Scand J Immunol; 1984 Jan; 19(1):63-73. PubMed ID: 6367020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
    Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
    J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of complement by 405-nm light in serum from porphyria cutanea tarda.
    Torinuki W; Miura T; Tagami H
    Arch Dermatol Res; 1985; 277(3):174-8. PubMed ID: 4015182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg.
    McCarthy K; Henson PM
    J Immunol; 1979 Dec; 123(6):2511-7. PubMed ID: 574148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments.
    Camussi G; Tetta C; Bussolino F; Cappio FC; Coda R; Masera C; Segoloni G
    Int Arch Allergy Appl Immunol; 1980; 62(1):1-15. PubMed ID: 7372359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
    Webster RO; Larsen GL; Henson PM
    J Clin Invest; 1982 Dec; 70(6):1177-83. PubMed ID: 7174788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
    Bergh K; Iversen OJ
    J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological properties of human C5a: selected in vitro and in vivo studies.
    Yancey KB
    Clin Exp Immunol; 1988 Feb; 71(2):207-10. PubMed ID: 3280183
    [No Abstract]   [Full Text] [Related]  

  • 35. Airway responses in vitro following C5a des Arg-induced hyper-responsiveness in vivo in rabbits.
    Armour CL; Black JL; Vincenc KS; Johnson PR; Ward H; Berend N
    Clin Exp Pharmacol Physiol; 1987 Jan; 14(1):7-14. PubMed ID: 3608241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des Arg in rabbits.
    Berend N; Armour CL; Black JL
    Agents Actions; 1986 Aug; 18(5-6):468-72. PubMed ID: 3766308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunologic defense mechanism of complement-derived inflammatory chemical mediators].
    Yamamoto T; Kambara T
    Nihon Rinsho; 1988 Sep; 46(9):1974-80. PubMed ID: 3266512
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.
    Wetsel RA; Jones MA; Kolb WP
    J Immunol Methods; 1980; 35(3-4):319-35. PubMed ID: 6995534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of Gc globulin (vitamin D binding protein) to C5a or C5a des Arg is not necessary for co-chemotactic activity.
    Kew RR; Mollison KW; Webster RO
    J Leukoc Biol; 1995 Jul; 58(1):55-8. PubMed ID: 7616106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C5a receptor of neutrophils and macrophages.
    Chenoweth DE; Goodman MG
    Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.